Scholars@Duke

"Understanding the Patient Experience of Stage 3 Unresectable Non-Small Cell Lung Cancer (NSCLC) in the Immuno-oncology Era"

Research Grant
Duke Scholars
Thomas William LeBlanc
Principal Investigator Thomas William LeBlanc Medicine, Hematologic Malignancies and Cellular Therapy
Jeffrey Melson Clarke
Co Investigator Jeffrey Melson Clarke Medicine, Medical Oncology
Steven Wolf
Statistician Steven Wolf  

Administered By

Duke Cancer Institute

Awarded By

AstraZeneca PLC

Start Date

December 10, 2020

End Date

May 13, 2022
 

Administered By

Duke Cancer Institute

Awarded By

AstraZeneca PLC

Start Date

December 10, 2020

End Date

May 13, 2022